Akers Biosciences Company Profile (NASDAQ:AKER)

About Akers Biosciences (NASDAQ:AKER)

Akers Biosciences logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AKER
  • CUSIP: N/A
  • Web: www.akerslaboratories.com
  • Market Cap: $12.84 million
  • Outstanding Shares: 8,853,000
Average Prices:
  • 50 Day Moving Avg: $1.62
  • 200 Day Moving Avg: $1.63
  • 52 Week Range: $1.15 - $3.70
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.83
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $2.96 million
  • Price / Sales: 4.34
  • Book Value: $0.62 per share
  • Price / Book: 2.34
  • EBIDTA: ($4,190,000.00)
  • Net Margins: -208.32%
  • Return on Equity: -114.05%
  • Return on Assets: -87.75%
  • Current Ratio: 2.95%
  • Quick Ratio: 1.46%
  • Average Volume: 237,408 shs.
  • Beta: -0.06
  • Short Ratio: 0.55

Frequently Asked Questions for Akers Biosciences (NASDAQ:AKER)

What is Akers Biosciences' stock symbol?

Akers Biosciences trades on the NASDAQ under the ticker symbol "AKER."

How were Akers Biosciences' earnings last quarter?

Akers Biosciences Inc (NASDAQ:AKER) issued its quarterly earnings data on Tuesday, May, 16th. The company reported ($0.19) earnings per share (EPS) for the quarter. The business earned $0.67 million during the quarter. Akers Biosciences had a negative return on equity of 114.05% and a negative net margin of 208.32%. View Akers Biosciences' Earnings History.

Who are some of Akers Biosciences' key competitors?

How do I buy Akers Biosciences stock?

Shares of Akers Biosciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Akers Biosciences stock cost?

One share of Akers Biosciences stock can currently be purchased for approximately $1.45.

Analyst Ratings

Consensus Ratings for Akers Biosciences (NASDAQ:AKER) (?)
Ratings Breakdown: 1 Sell Rating
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: N/A

Analysts' Ratings History for Akers Biosciences (NASDAQ:AKER)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/18/2017ValuEngineDowngradeHold -> SellMediumView Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Akers Biosciences (NASDAQ:AKER)
Earnings by Quarter for Akers Biosciences (NASDAQ:AKER)
Earnings History by Quarter for Akers Biosciences (NASDAQ:AKER)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/16/20173/31/2017($0.19)$0.67 millionViewN/AView Earnings Details
11/14/2016Q316$0.04$0.06$0.61 millionViewN/AView Earnings Details
8/11/2016Q216($0.19)$0.96 millionViewListenView Earnings Details
11/13/2015Q315($0.36)$0.17 millionViewListenView Earnings Details
8/18/2015Q215($0.41)$1.35 million$0.97 millionViewListenView Earnings Details
5/14/2015Q115($0.10)($0.26)$2.00 million$0.51 millionViewListenView Earnings Details
11/13/2014Q314($0.17)($0.23)$1.40 million$453.30 millionViewN/AView Earnings Details
8/12/2014Q2 2014($0.16)($0.10)$1.35 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Akers Biosciences (NASDAQ:AKER)
Current Year EPS Consensus Estimate: $-1.24 EPS
Next Year EPS Consensus Estimate: $-0.30 EPS


Dividend History for Akers Biosciences (NASDAQ:AKER)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Akers Biosciences (NASDAQ:AKER)
Insider Ownership Percentage: 16.31%
Institutional Ownership Percentage: 3.24%
Insider Trades by Quarter for Akers Biosciences (NASDAQ:AKER)
Insider Trades by Quarter for Akers Biosciences (NASDAQ:AKER)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2016John J GormallyCEOBuy2,500$2.23$5,575.00View SEC Filing  
1/5/2016Raymond Francis Akers JrChairmanBuy2,100$1.34$2,814.00View SEC Filing  
12/11/2015Gary M RauchVPBuy3,500$1.50$5,250.00View SEC Filing  
8/22/2014Gary M RauchVPBuy1,020$3.15$3,213.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Akers Biosciences (NASDAQ:AKER)
Latest Headlines for Akers Biosciences (NASDAQ:AKER)
americanbankingnews.com logoAkers Biosciences Inc (AKER) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - May 18 at 4:40 PM
americanbankingnews.com logoAkers Biosciences Inc (AKER) Posts Quarterly Earnings Results
www.americanbankingnews.com - May 17 at 10:02 AM
reuters.com logoBRIEF-Akers Biosciences reports 10 pct fall in Q1 revenue
www.reuters.com - May 16 at 8:31 PM
seekingalpha.com logoAkers Biosciences' (AKER) CEO John Gormally on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 8:31 PM
finance.yahoo.com logoAkers Biosciences Updates on Akers Wellness(TM) Tests
finance.yahoo.com - April 24 at 10:51 AM
americanbankingnews.com logoAkers Biosciences (AKER) Receiving Somewhat Positive Media Coverage, Analysis Shows
www.americanbankingnews.com - April 18 at 8:51 AM
finance.yahoo.com logoAkers Biosciences, Inc. :AKER-US: Earnings Analysis: Q4, 2016 By the Numbers : April 13, 2017
finance.yahoo.com - April 13 at 3:38 PM
finance.yahoo.com logoEdited Transcript of AKER earnings conference call or presentation 11-Apr-17 1:00pm GMT
finance.yahoo.com - April 12 at 11:45 AM
morningstar.co.uk logoAkers Bioscience 2016 Loss Narrows Amid Sales Growth, Cost Cutting
www.morningstar.co.uk - April 11 at 3:27 PM
finance.yahoo.com logoAkers Biosciences to Commercialize Heparin PF4 Rapid Test in Puerto Rico
finance.yahoo.com - April 10 at 3:25 PM
reuters.com logoBRIEF-Akers Biosciences files for non-timely 10-K - SEC filing
www.reuters.com - April 1 at 10:04 AM
reuters.com logoBRIEF-Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016
www.reuters.com - March 31 at 3:32 PM
reuters.com logoBRIEF-Akers Biosciences announces a $2 million private placement
www.reuters.com - March 30 at 8:50 PM
morningstar.co.uk logoAkers Biosciences Delays Results But Says Revenue Up 40% In 2016
www.morningstar.co.uk - March 30 at 8:50 PM
finance.yahoo.com logoAkers Biosciences Announces a $2 Million Private Placement
finance.yahoo.com - March 30 at 8:50 PM
biz.yahoo.com logoFull Year 2016 Akers Biosciences Inc Earnings Release - Time Not Supplied
us.rd.yahoo.com - March 30 at 3:50 PM
us.rd.yahoo.com logoAkers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016
us.rd.yahoo.com - March 30 at 3:50 PM
finance.yahoo.com logoAkers Biosciences Announces Conference Call to Discuss FY 2016 Earnings
finance.yahoo.com - March 29 at 10:14 AM
finance.yahoo.com logoAkers Receives Cholesterol Test Kit Order from First Check
finance.yahoo.com - March 29 at 10:14 AM
finance.yahoo.com logoHow Will Rapid Cholesterol Test Relate to Potential Future Revenue for Akers
finance.yahoo.com - March 29 at 10:14 AM
finance.yahoo.com logoDiffusion Pharmaceuticals Gets Professional Recognition and Akers Biosciences Achieves a First
finance.yahoo.com - March 29 at 10:14 AM
nasdaq.com logoMid-Day Market Update: Exeter Gains On Acquisition News; CryoPort Shares Slide
www.nasdaq.com - March 28 at 3:26 PM
reuters.com logoBRIEF-Akers Biosciences begins selling rapid cholesterol test
www.reuters.com - March 28 at 8:55 AM
morningstar.co.uk logoAkers Gets US Patent For Cartridge Used In BreathScan Lync
www.morningstar.co.uk - February 16 at 7:37 AM
finance.yahoo.com logoAkers Biosciences Allowed US Patent for Akers Wellness(TM) Tests Cartridge
finance.yahoo.com - February 16 at 7:37 AM
finance.yahoo.com logoAkers Biosciences Announces Closing of Public Offering
finance.yahoo.com - January 13 at 8:51 PM
streetinsider.com logoForm 8-K Akers Biosciences Inc For: Jan 13
www.streetinsider.com - January 13 at 3:49 PM
biz.yahoo.com logoAKERS BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 13 at 3:49 PM
biz.yahoo.com logoAKERS BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - January 10 at 8:30 PM
reuters.com logoBRIEF-Akers Biosciences prices 1.6 mln share offering at $1.20 per share
www.reuters.com - January 10 at 3:28 PM
finance.yahoo.com logo3:20 am Akers Biosciences prices 1,667,000 shares of common stock at $1.20 per share, together with 833,500 five-year warrants to purchase common stock with an exercise price of $1.50
finance.yahoo.com - January 10 at 3:28 PM
marketwatch.com logoAkers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants
www.marketwatch.com - January 9 at 8:39 PM
streetinsider.com logoForm 424B5 Akers Biosciences Inc
www.streetinsider.com - January 6 at 3:32 PM
biz.yahoo.com logoAKERS BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - December 22 at 8:29 PM
baystreet.ca logoAkers Biosciences (AKER) Gains on New York State deal
www.baystreet.ca - December 22 at 3:27 PM
morningstar.co.uk logoAkers Biosciences Signs Rapid Test Deal With US Hospital Association
www.morningstar.co.uk - December 20 at 9:04 AM
streetinsider.com logoAkers Biosciences (AKER) Signs Three Agreement with GNYHA to Introduce Heparin PF4 Rapid Test
www.streetinsider.com - December 19 at 3:36 PM
morningstar.co.uk logoAkers Agrees Deal For First Check To Sell Cholesterol Test In US
www.morningstar.co.uk - December 1 at 8:30 PM
us.rd.yahoo.com logo5:00 am Akers Biosciences completes the clinical trial for Diabetic Ketoacidosis Breath Test
us.rd.yahoo.com - November 30 at 8:27 PM
morningstar.co.uk logoAkers Biosciences: Clinical Trial For BreathScan "Highly Successful"
www.morningstar.co.uk - November 29 at 1:02 PM
streetinsider.com logoAkers Biosciences (AKER) Announces Completion of BreathScan DKA Trial; Results Seen as 'Highly Successful'
www.streetinsider.com - November 29 at 1:02 PM
finance.yahoo.com logoAkers Biosciences Completes Clinical Trial for Rapid Diabetic Ketoacidosis Breath Test
finance.yahoo.com - November 29 at 1:02 PM
finance.yahoo.com logoAKERS BIOSCIENCES INC Financials
finance.yahoo.com - November 17 at 1:44 PM
reuters.com logoBRIEF-Akers Biosciences files for potential stock shelf, size not disclosed
www.reuters.com - November 16 at 3:28 PM



Akers Biosciences (AKER) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff